Key Statistics
Market Cap$4.02B
P/E RatioN/A
Div. Yield—
EPS (TTM)-$3.19
52W High$43.15
52W Low$18.92
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees53
Price Performance
1 Week+7.01%
3 Month+8.28%
1 Year+43.68%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$368.49M
Liabilities$20.07M
Net Income$85.89M loss
About
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered in San Diego, California.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze VKTX with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.